Back to Search Start Over

Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.

Authors :
Schubl SD
Figueroa C
Palma AM
de Assis RR
Jain A
Nakajima R
Jasinskas A
Brabender D
Hosseinian S
Naaseh A
Hernandez Dominguez O
Runge A
Skochko S
Chinn J
Kelsey AJ
Lai KT
Zhao W
Horvath P
Tifrea D
Grigorian A
Gonzales A
Adelsohn S
Zaldivar F
Edwards R
Amin AN
Stamos MJ
Barie PS
Felgner PL
Khan S
Source :
BMC infectious diseases [BMC Infect Dis] 2023 May 16; Vol. 23 (1), pp. 330. Date of Electronic Publication: 2023 May 16.
Publication Year :
2023

Abstract

Background: While others have reported severe acute respiratory syndrome-related coronavirus 2(SARS-CoV-2) seroprevalence studies in health care workers (HCWs), we leverage the use of a highly sensitive coronavirus antigen microarray to identify a group of seropositive health care workers who were missed by daily symptom screening that was instituted prior to any epidemiologically significant local outbreak. Given that most health care facilities rely on daily symptom screening as the primary method to identify SARS-CoV-2 among health care workers, here, we aim to determine how demographic, occupational, and clinical variables influence SARS-CoV-2 seropositivity among health care workers.<br />Methods: We designed a cross-sectional survey of HCWs for SARS-CoV-2 seropositivity conducted from May 15th to June 30th 2020 at a 418-bed academic hospital in Orange County, California. From an eligible population of 5,349 HCWs, study participants were recruited in two ways: an open cohort, and a targeted cohort. The open cohort was open to anyone, whereas the targeted cohort that recruited HCWs previously screened for COVID-19 or work in high-risk units. A total of 1,557 HCWs completed the survey and provided specimens, including 1,044 in the open cohort and 513 in the targeted cohort. Demographic, occupational, and clinical variables were surveyed electronically. SARS-CoV-2 seropositivity was assessed using a coronavirus antigen microarray (CoVAM), which measures antibodies against eleven viral antigens to identify prior infection with 98% specificity and 93% sensitivity.<br />Results: Among tested HCWs (nā€‰=ā€‰1,557), SARS-CoV-2 seropositivity was 10.8%, and risk factors included male gender (OR 1.48, 95% CI 1.05-2.06), exposure to COVID-19 outside of work (2.29, 1.14-4.29), working in food or environmental services (4.85, 1.51-14.85), and working in COVID-19 units (ICU: 2.28, 1.29-3.96; ward: 1.59, 1.01-2.48). Amongst 1,103 HCWs not previously screened, seropositivity was 8.0%, and additional risk factors included younger age (1.57, 1.00-2.45) and working in administration (2.69, 1.10-7.10).<br />Conclusion: SARS-CoV-2 seropositivity is significantly higher than reported case counts even among HCWs who are meticulously screened. Seropositive HCWs missed by screening were more likely to be younger, work outside direct patient care, or have exposure outside of work.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
1471-2334
Volume :
23
Issue :
1
Database :
MEDLINE
Journal :
BMC infectious diseases
Publication Type :
Academic Journal
Accession number :
37194021
Full Text :
https://doi.org/10.1186/s12879-023-08284-y